<?xml version="1.0" encoding="UTF-8"?>
<!--Generated by Squarespace Site Server v5.11.81 (http://www.squarespace.com/) on Thu, 31 May 2012 16:07:34 GMT--><feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/"><title>Press/Media</title><subtitle>Press/Media</subtitle><id>http://www.eyesthetica.com/press/</id><link rel="alternate" type="application/xhtml+xml" href="http://www.eyesthetica.com/press/"/><link rel="self" type="application/atom+xml" href="http://www.eyesthetica.com/press/atom.xml"/><updated>2011-02-18T20:49:39Z</updated><generator uri="http://www.squarespace.com/" version="Squarespace Site Server v5.11.81 (http://www.squarespace.com/)">Squarespace</generator><entry><title>Media #1</title><id>http://www.eyesthetica.com/press/2011/2/4/media-1.html</id><link rel="alternate" type="text/html" href="http://www.eyesthetica.com/press/2011/2/4/media-1.html"/><author><name>Eyesthetica</name></author><published>2011-02-04T20:48:00Z</published><updated>2011-02-04T20:48:00Z</updated><content type="html" xml:lang="en-US"><![CDATA[<p>embedded video</p>]]></content></entry><entry><title>Press/Article #1</title><id>http://www.eyesthetica.com/press/2011/2/4/pressarticle-1.html</id><link rel="alternate" type="text/html" href="http://www.eyesthetica.com/press/2011/2/4/pressarticle-1.html"/><author><name>Eyesthetica</name></author><published>2011-02-04T20:47:00Z</published><updated>2011-02-04T20:47:00Z</updated><content type="html" xml:lang="en-US"><![CDATA[<p>excerpt and link.</p>]]></content></entry></feed>
